SightfileU.S. market data from official filings

ABCELLERA BIOLOGICS INC (ABCL)

Name: ABCELLERA BIOLOGICS INC (ABCL) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001703057 · EDGAR filings · Updated 2026-07-06

ABCELLERA BIOLOGICS INC (ABCL) has reported institutional ownership of 40.7%, with 137 institutional managers holding positions valued at $434.0M per the latest 13F reporting period.

Institutional ownership

40.7%

Institutional managers

137

Reported 13F value

$434.0M

Insider activity

5 trans.

$1.04M net buying

Latest updates

2026-07-06 — Insider transaction reported (Form 4)
2026-07-06 — Initial insider ownership filed (Form 3)
2026-07-06 — Insider transaction reported (Form 4)
2026-07-06 — Current report (8-K) filed
2026-06-17 — Current report (8-K) filed
2026-06-12 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ABCELLERA BIOLOGICS INC has 137 institutional holders and institutional ownership of 40.7%.

Insider activity

Insiders reported 5 transactions (4 buys, 0 sells) across 4 reporting insiders, with a net reported value of $1.04M.

Related companies

MANNKIND CORP (MNKD) · ETON PHARMACEUTICALS INC (ETON) · ANGIODYNAMICS INC (ANGO) · DBV TECHNOLOGIES S A (DBVT) · VERASTEM INC (VSTM) · RIGEL PHARMACEUTICALS INC (RIGL)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-06.